APA (7th ed.) Citation

S, K., RJ, E., D, V., CRF, R., S, S., EN, L., . . . A, G. (2026). Risk factors and challenge outcomes in trimethoprim-sulfamethoxazole hypersensitivity in HIV-negative patients: A multicenter retrospective report. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 136(2), 204. https://doi.org/10.1016/j.anai.2025.09.008

Chicago Style (17th ed.) Citation

S, Kinate, Estrada-Mendizabal RJ, Voelker D, Rukasin CRF, Shama S, Labib EN, Rank MA, Park MA, and Gonzalez-Estrada A. "Risk Factors and Challenge Outcomes in Trimethoprim-sulfamethoxazole Hypersensitivity in HIV-negative Patients: A Multicenter Retrospective Report." Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology 136, no. 2 (2026): 204. https://doi.org/10.1016/j.anai.2025.09.008.

MLA (9th ed.) Citation

S, Kinate, et al. "Risk Factors and Challenge Outcomes in Trimethoprim-sulfamethoxazole Hypersensitivity in HIV-negative Patients: A Multicenter Retrospective Report." Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology, vol. 136, no. 2, 2026, p. 204, https://doi.org/10.1016/j.anai.2025.09.008.